The 19-kDa fragment containing two epidermal growth factor (EGF)-like domains has been considered to be a potential vaccine candidate because it is a target for invasion inhibitory antibodies while naturally acquired antibodies against this fragment have been associated with protection against symptomatic malaria among individuals living in malaria endemic areas25,26. Here, EGF is linked to malaria.